Dharmanol discussion here has focused on non-psychoactive

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles
Dharmanol discussion here has focused on non-psychoactive CBD and THCA as two powerful medicinal agents. Little has been said about CBDA. THCA and CBDA are both cannabinoid carboxylates. Dharmanol, with its CBD and "mixed cannabinoid carboxylates," would also contain CBDA.

We know that THC is the psychocactive delta9-tetrahydrocannabinol which, in its native form in the living cannabis plant, is non-psychoactive tetrahydrocannabinolic acid (THCA or 2-COOH-THC). Heating, vaporizing or drying THCA strips off (decarboxylates) the carboxyl radical (-COOH) leaving psychoactive THC. CBDA is  cannabidiolic acid. As with THCA, stripped of its -COOH radical, it becomes CBD or cannabidiol.

H-COOH is the simplest carboxylic organic acid. Called formic acid, it has the odor of ants (genus formica). Formic acid is found in ant venom. CH3-COOH is acetic acid, the sour chemical in vinegar. It's thought that THCA and CBDA help protect the cannabis plant from microbial and insect predation.

Recent research has shown CBDA, which has anti-inflammatory properties greater than THCA, to have powerful healing properties including management of schizophrenia.

According to Dr. Mitch Earleywine, researchers at Harvard showed that CBDA makes breast cancer cells kill themselves and researchers in Japan found CBDA keeps breast cancer cells from spreading.

This is further evidence that Berkeley Bio's proprietary and carefully calibrated Whole Plant Plus technology, to coin a phrase, as formulated in Dharmanol™ is the correct scientific and medical methodology that will win the marketplace.

From Hoye essay:

"Along with the CBD and mixed cannabinoid carboxylates, the third component of Dharmanol™ is a steam-distilled extract of a variety of strains of cannabis. This preparation contains the terpenes and terpenoids found in marijuana, many of which have been shown to have substantial medicinal value in themselves, as well as potentiating the activity of some of the cannabinoids."

"Low-dose tablets contain 5mg. CBD, 5 mg. mixed cannabinoid carboxylates, and 5 mg. of steam-distilled terpenes and terpenoids. A daily supplement such as this will gently stimulate the endo-cannabinoid system, which regulates and enhances many of the body’s own health-promoting processes, such as the immune system. These are the systems that keep cancer and other opportunistic diseases in check in otherwise-healthy individuals."

More on Dharmanol™ in the Hoye essay on :

"CBD is an important part of Dharmanol™ a new natural medicine recently developed by Berkeley Bio. Along with CBD, Dharmanol™ contains a wide array of natural cannabinoids that have been extracted from hemp/cannabis and preserved in their non-psychoactive form utilizing a proprietary technology developed by Gold and Apel."

"...the carboxylates present in Dharmanol™ go a long way towards providing the same benefits without the extreme difficulty of maintaining live marijuana plants."

"Dharmanol™ has been designed to provide the widest spectrum of beneficial compounds of the cannabis plant, in their non-psychoactive form..." 

" Dharmanol™ has been designed to provide the widest spectrum of beneficial compounds of the cannabis plant, in their non-psychoactive form, just as the aforementioned capsules provided the widest healing array possible, but included the psychoactive THC."

"Dharmanol™ has been designed to treat any of the myriad of conditions for which physicians are now recommending that patients try cannabinoid medicine. Modern research tells us that this includes treatments for a great number of different conditions."

"Two additional benefits are present with Dharmanol™ that are not to be found with standard Simpson therapy. The removal of the psychoactivity allows patients who cannot tolerate Simpson oil to treat their conditions with adequate amounts of cannabinoids, and the removal of the psychoactivity allows patients to tolerate much larger doses."

"The capacity to increase the dosage by removing the psychoactivity holds much promise. The “standard” Simpson dose is well under one one-thousandth of the dose of cannabinoids said to be capable of causing physical harm to the organism. The reason that one gram is the dose recommended by Simpson is that few people could possibly tolerate more than this."

"With the amazing anecdotal results surrounding Simpson oil, combined with the fact that many of cannabis’ mechanisms are dose-dependent, it stands to reason that increasing the daily dose of cannabinoids ten, or perhaps one hundred times, could provide a medicine that no cancer could possibly stand up against. Hopefully, clinical trials of Dharmanol™ will show whether this is so."


SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

Terra Innovatum Secures $37.5 Million to Advance Technology

Updated Category News Views 284

Terra Innovatum Secures $37.5 Million Funding for Innovative Reactor In an exciting development, Terra Innovatum, a pioneering company in micro-modular nuclear reactor technology, has successfully secured $37.5 million for its upcoming public debut. The financing aims to bolster the construction and licensing of the company’s groundbreaking SOLO™ micro-modular...

Continue Reading
Tryg A/S Consensus Estimates: Analyst Insights for 2025

Updated Category News Views 169

Understanding Consensus Estimates for Tryg A/S In the financial world, consensus estimates play a crucial role in gauging the anticipated performance of a company based on the predictions of financial analysts. Ahead of the interim report for Q1-Q3 2025, Tryg A/S has gathered insights from a diverse group of 15 financial analysts, providing a clearer picture of what to...

Continue Reading
Robert Downey Jr. Blesses Disney's New Cruise Ship Adventure

Updated Category News Views 220

The Glitzy Dive into the Disney Adventure Celebrating a fresh chapter, Disney just made waves by announcing that none other than Robert Downey Jr. will be the godparent of its newest ship, the Disney Adventure. This massive vessel, making its grand debut from Singapore, promises to be a game changer, and honestly, this kinda gets me fired up! I mean, look at the kind of...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 6

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
Cisco's Chief Discusses Entry-Level Hiring Trends and AI

Updated Category News Views 175

Cisco's Insights on Entry-Level Hiring Trends The landscape of entry-level job opportunities is seeing a notable shift. Data from an industry student platform reveals a decrease in job postings for recent graduates. The statistics indicate a 16% year-over-year drop in entry-level positions, sparking concern among graduates and job seekers. Understanding the Current Job...

Continue Reading